Home / Conditions / Type 2 Diabetes (page 26)

Type 2 Diabetes

Type 2 Diabetes Research and News: Type 2 diabetes is a metabolic disorder. Though most commonly diagnosed in the elderly, younger adults and even children are increasingly subject to the disease. 9.4% of the US population has Type 2 diabetes or about 30 million Americans. Approximately 95% of all adults diagnosed with diabetes have Type 2. New tools, techniques and treatments can help you improve outcomes for your Type 2 diabetes patients.

Prescribing Exercise in Type 2 Diabetes: What the Evidence Says About Type, Dose, and Impact

A glucose meter, exercise prescription form, athletic shoes, and dumbbell illustrating the integration of fitness into type 2 diabetes care.

Exercise is a cornerstone of type 2 diabetes care, yet clinicians often struggle with translating broad guidelines into practical, individualized “exercise prescriptions.” The focus keyword in this article, exercise prescription for type 2 diabetes, reflects a high‑intent search term that clinicians, diabetes educators, and patients frequently use when seeking actionable …

Read More »

The Expanding Landscape of Diabetes Complications: Liver Disease, Cancer, and Frailty

Illustration showing liver disease, cancer risk, brain health, and frailty in diabetes-related complications.

Early in training, many clinicians learn the classic “eye–kidney–foot” framework for recognizing and managing complications of diabetes. However, as science advances, the range of recognized consequences of diabetes—and opportunities for earlier intervention—continues to broaden. Today, the concept of diabetes complications screening must evolve to include conditions such as metabolic dysfunction–associated …

Read More »

Beyond GLP‑1s: Are We Overlooking the Role of SGLT2 Inhibitors and Metformin?

Assorted diabetes medications including metformin and SGLT2 inhibitors arranged on a wooden surface beside a white pill bottle.

Clinicians and care teams are increasingly focused on GLP‑1 receptor agonists, but SGLT2 inhibitors and metformin in diabetes management remain foundational in achieving comprehensive, evidence‑based outcomes. While GLP‑1 therapies generate headlines for weight loss and glucose control, 2025 guidelines still strongly emphasize the cardioprotective and renoprotective benefits of SGLT2 inhibitors …

Read More »

When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus

Medical stethoscope, glucose meter, and a clipboard showing icons for heart, kidneys, and brain, symbolizing comorbidities in type 2 diabetes management.

Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …

Read More »

From A1C to TIR – Rethinking Glycemic Targets for Better Long‑Term Outcomes

A glucose meter reading 117 mg/dL placed over lab results showing Hemoglobin A1c and a Time in Range (TIR) chart with green, yellow, and red bars.

For decades, clinicians have relied on A1C as the primary benchmark for diabetes control. Yet many patients and providers now wonder: does a single quarterly number truly reflect daily glucose fluctuations and risks? As continuous glucose monitoring (CGM) becomes more accessible, the metric known as Time in Range (TIR) has …

Read More »

Should We Be Prescribing Exercise as a Formal Diabetes Intervention?

Diabetes management tools including a prescription pad, glucose meters, teal dumbbells, jump rope, and water bottle on a wooden surface.

When treating patients with diabetes, lifestyle advice such as “eat healthy” and “stay active” is often routine. But what if we took that a step further and issued a formal exercise prescription — in other words, ordering physical activity like we would a drug? Recent research suggests that a structured …

Read More »

The Case for Early Insulin: Rethinking Delayed Initiation in Type 2 Diabetes

A female doctor explains insulin injection using a pen device to a middle-aged male patient, with a glucose monitor and tablet displaying a blood sugar graph on the table.

Starting insulin early in the course of type 2 diabetes may seem counter‑intuitive. After all, many patients and clinicians treat insulin as a “last resort.” Yet what if early insulin initiation could actually change the trajectory of the disease — preserving pancreatic function, improving long‑term control, and reducing complications? In …

Read More »